Join
Live feed
·
SECFilingvia Quantisnow
Allogene Therapeutics Inc. logo

Allogene Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Costs Associated with Exit or Disposal Activities

ByQuantisnow·Wall Street's wire, on your screen.
ALLO· Allogene Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLO (Allogene Therapeutics Inc.) and more on Quantisnow.

Allogene Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Costs Associated with Exit or Disposal Activities | Quantisnow